65 related articles for article (PubMed ID: 7577208)
21. Cisplatin/etoposide vs paclitaxel/cisplatin/G-CSF vs paclitaxel/cisplatin in non-small-cell lung cancer.
Bonomi P; Kim K; Kusler J; Johnson D
Oncology (Williston Park); 1997 Apr; 11(4 Suppl 3):9-10. PubMed ID: 9144683
[TBL] [Abstract][Full Text] [Related]
22. Taxol (paclitaxel) in the treatment of lung cancer: the Eastern Cooperative Oncology Group experience.
Johnson DH; Chang AY; Ettinger DS
Ann Oncol; 1994; 5 Suppl 6():S45-50. PubMed ID: 7865434
[TBL] [Abstract][Full Text] [Related]
23. Recent advances with chemotherapy for NSCLC: the ECOG experience. Eastern Cooperative Oncology Group.
Johnson DH; Chang AY; Ettinger DS; Kim KM; Bonomi P
Oncology (Williston Park); 1998 Jan; 12(1 Suppl 2):67-70. PubMed ID: 9516615
[TBL] [Abstract][Full Text] [Related]
24. Eastern Cooperative Oncology Group experience with chemotherapy in advanced non-small cell lung cancer.
Bonomi P
Chest; 1998 Jan; 113(1 Suppl):13S-16S. PubMed ID: 9438684
[TBL] [Abstract][Full Text] [Related]
25. Platinum/etoposide therapy in non-small cell lung cancer.
Bonomi P
Oncology; 1992; 49 Suppl 1():43-50. PubMed ID: 1323811
[TBL] [Abstract][Full Text] [Related]
26. Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial.
Langer CJ; Manola J; Bernardo P; Kugler JW; Bonomi P; Cella D; Johnson DH
J Natl Cancer Inst; 2002 Feb; 94(3):173-81. PubMed ID: 11830607
[TBL] [Abstract][Full Text] [Related]
27. Phase II trial of acivicin versus etoposide-cisplatin in non-small cell lung cancer. An Eastern Cooperative Oncology Group study.
Bonomi P; Finkelstein D; Chang A
Am J Clin Oncol; 1994 Jun; 17(3):215-7. PubMed ID: 8192104
[TBL] [Abstract][Full Text] [Related]
28. The combination of etoposide and cisplatin in non-small-cell lung cancer (NSCLC).
Ardizzoni A; Antonelli G; Grossi F; Tixi L; Cafferata M; Rosso R
Ann Oncol; 1999; 10 Suppl 5():S13-7. PubMed ID: 10582133
[TBL] [Abstract][Full Text] [Related]
29. Etoposide and doxorubicin antagonize the in vitro activity of paclitaxel in human non-small cell lung cancer cell lines.
Viallet J; Tsao MS; Gallant G
Lung Cancer; 1996 Aug; 15(1):93-101. PubMed ID: 8865127
[TBL] [Abstract][Full Text] [Related]
30. Lung cancer highlights.
Lynch TJ
Oncologist; 2000; 5(4):274-9. PubMed ID: 10964993
[TBL] [Abstract][Full Text] [Related]
31. Response to 'Survival advantage for etoposide/cisplatin over paclitaxel/carboplatin concurrent chemoradiation in patients with inoperable stage III NSCLC: a subgroup analysis for ECOG 2 patients would be of great interest'.
Bi N; Liang J; Wang L
Ann Oncol; 2017 Dec; 28(12):3101-3103. PubMed ID: 29045508
[No Abstract] [Full Text] [Related]
32. Novel chemotherapeutic agents in the treatment of non-small-cell lung cancer.
Lilenbaum RC; Green MR
J Clin Oncol; 1993 Jul; 11(7):1391-402. PubMed ID: 8391068
[TBL] [Abstract][Full Text] [Related]
33. Paclitaxel and cisplatin in the treatment of metastatic non-small-cell lung cancer during pregnancy.
García-González J; Cueva J; Lamas MJ; Curiel T; Graña B; López-López R
Clin Transl Oncol; 2008 Jun; 10(6):375-6. PubMed ID: 18558586
[TBL] [Abstract][Full Text] [Related]
34. The Role of Systemic Therapy in Patients with Advanced Non-small Cell Lung Cancer and a Poor Eastern Cooperative Oncology Group Performance Status.
Shah M; Noronha V; Patil V; Menon N; Singh AK; Shah A; Kumar P; Roychoudhary O; Peelay Z; Janu A; Purandare N; Chakrabarty N; Patil V; Kaushal R; Shetty O; Pai T; Chandrani P; Chougule A; Prabhash K
Clin Oncol (R Coll Radiol); 2024 Feb; 36(2):128-129. PubMed ID: 38097463
[No Abstract] [Full Text] [Related]
35. Paclitaxel/etoposide/cisplatin versus etoposide/cisplatin for small-cell lung cancer.
Clin Lung Cancer; 2000 Feb; 1(3):175-6. PubMed ID: 14733639
[No Abstract] [Full Text] [Related]
36. Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): a trial of the Eastern Cooperative Oncology Group.
Richie JP
J Urol; 2003 Jun; 169(6):2418-9. PubMed ID: 14558529
[No Abstract] [Full Text] [Related]
37. Phase II and III trials: comparison of four chemotherapy regimens in advanced non small-cell lung cancer (ECOG 1594).
Fisher MD; D'Orazio A
Clin Lung Cancer; 2000 Aug; 2(1):21-2. PubMed ID: 14731332
[No Abstract] [Full Text] [Related]
38. Treatment outcomes in elderly with advanced-stage non-small cell lung cancer.
Tam TC; Ho JC; Wong MK; Wong WM; Wang JK; Lam JC; Lui MM; Lam WK; Ip MS; Lam DC
Lung; 2013 Dec; 191(6):645-54. PubMed ID: 23929397
[TBL] [Abstract][Full Text] [Related]
39. Treatment of advanced non small cell lung cancer in routine care: a retrospective analysis of 212 consecutive patients treated in a community based oncology group practice.
Koeppler H; Heymanns J; Thomalla J; Kleboth K; Mergenthaler U; Weide R
Clin Med Oncol; 2009 May; 3():63-70. PubMed ID: 20689611
[TBL] [Abstract][Full Text] [Related]
40. Platinum drugs in the treatment of non-small-cell lung cancer.
Cosaert J; Quoix E
Br J Cancer; 2002 Oct; 87(8):825-33. PubMed ID: 12373594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
